Another Off-Label Claim Dispute between Industry and FDA: Amarin’s Vascepa (Omega 3 Fatty Acid) 

FDA strictly enforces prevention of off-label promotion of products. In the recent past, there have been numerous cases of FDA’s punitive actions against companies and individuals accused of off-label promotion. US courts have repeated sided with FDA in agreeing that off-label promotion is not protected by free speech rights. Now Amarin Corporation, the manufacturer of … Read more

FDA Raises Concerns Regarding Security of Software Running Medical Devices

Certain infusion pumps such as Hospira LifeCare PCA3 and PCA5, used to supply of therapeutic and anesthetic drugs are controlled by software that communicates remotely with controllers and wireless networks. Such systems create a potential security vulnerability of hacking into the device and altering operation. Though so far there have been no reports of unauthorized … Read more